GIORGINO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 24.590
AS - Asia 10.280
EU - Europa 7.264
SA - Sud America 2.859
AF - Africa 336
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 12
Totale 45.356
Nazione #
US - Stati Uniti d'America 24.286
SG - Singapore 4.556
CN - Cina 2.511
BR - Brasile 2.464
HK - Hong Kong 1.499
IT - Italia 1.421
SE - Svezia 1.289
RU - Federazione Russa 1.061
DE - Germania 873
UA - Ucraina 803
VN - Vietnam 687
FI - Finlandia 516
GB - Regno Unito 471
IN - India 251
FR - Francia 249
ID - Indonesia 163
AR - Argentina 149
CA - Canada 148
CI - Costa d'Avorio 114
BD - Bangladesh 112
MX - Messico 95
PL - Polonia 86
BE - Belgio 83
AT - Austria 79
NL - Olanda 79
IE - Irlanda 70
IQ - Iraq 70
JP - Giappone 69
EC - Ecuador 67
ZA - Sudafrica 61
ES - Italia 58
TR - Turchia 57
VE - Venezuela 44
PK - Pakistan 43
MA - Marocco 33
UZ - Uzbekistan 30
LT - Lituania 29
CO - Colombia 28
EG - Egitto 28
SA - Arabia Saudita 28
PE - Perù 27
AE - Emirati Arabi Uniti 25
KR - Corea 24
TN - Tunisia 24
PY - Paraguay 23
CL - Cile 22
UY - Uruguay 20
CZ - Repubblica Ceca 19
CH - Svizzera 18
KE - Kenya 18
NP - Nepal 18
JO - Giordania 14
LB - Libano 14
JM - Giamaica 13
AZ - Azerbaigian 12
DZ - Algeria 12
IL - Israele 12
AU - Australia 11
BO - Bolivia 11
GR - Grecia 11
IR - Iran 9
KZ - Kazakistan 9
MY - Malesia 9
SN - Senegal 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
PH - Filippine 8
BG - Bulgaria 7
EU - Europa 7
HN - Honduras 7
KG - Kirghizistan 7
PA - Panama 7
PS - Palestinian Territory 7
HU - Ungheria 6
AM - Armenia 5
BY - Bielorussia 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AL - Albania 4
BZ - Belize 4
CR - Costa Rica 4
GE - Georgia 4
NG - Nigeria 4
NI - Nicaragua 4
OM - Oman 4
RO - Romania 4
SY - Repubblica araba siriana 4
BB - Barbados 3
GT - Guatemala 3
HR - Croazia 3
LY - Libia 3
ML - Mali 3
NZ - Nuova Zelanda 3
RS - Serbia 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
Totale 45.307
Città #
Fairfield 2.562
Singapore 2.393
Ashburn 2.352
Woodbridge 2.146
Jacksonville 1.870
Chandler 1.866
Houston 1.488
Hong Kong 1.485
Cambridge 1.051
Seattle 976
Ann Arbor 973
Nyköping 969
Wilmington 806
Beijing 597
Roxbury 508
Lawrence 499
Dearborn 483
Nanjing 467
New York 395
Bari 341
Los Angeles 339
Boardman 309
Des Moines 303
Dallas 293
Ho Chi Minh City 229
São Paulo 195
Inglewood 178
Princeton 175
Brooklyn 151
Buffalo 142
San Diego 134
Munich 133
Nanchang 130
Hebei 125
Jakarta 119
Hanoi 118
Abidjan 114
Shenyang 111
Santa Clara 110
London 105
Moscow 89
Rio de Janeiro 89
Helsinki 84
Jiaxing 84
Brussels 82
Tianjin 80
Chicago 74
Belo Horizonte 72
Paris 70
Guangzhou 69
Nuremberg 69
Dublin 66
Warsaw 66
Dong Ket 63
Hefei 61
Pune 60
Council Bluffs 59
Changsha 56
Jinan 56
Tokyo 55
Falkenstein 52
Montreal 52
Rome 52
Curitiba 50
Phoenix 50
Redwood City 49
Chennai 45
Frankfurt am Main 45
Kunming 44
Porto Alegre 42
Columbus 41
Atlanta 38
Denver 37
Orem 36
San Jose 35
Turku 35
Brasília 34
Campinas 34
Haiphong 34
San Francisco 34
Shanghai 34
Johannesburg 33
Vienna 33
Poplar 32
Stockholm 32
Toronto 32
Hyderabad 30
Manchester 30
The Dalles 30
Mexico City 29
Zhengzhou 29
Baghdad 28
Boston 27
Norwalk 27
Quito 27
Amsterdam 26
Salvador 26
Auburn Hills 25
Milan 25
Tashkent 25
Totale 30.563
Nome #
Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy 235
Long-term exposure of pancreatic β-cells to palmitate results in SREBP-1C-dependent decreases in GLP-1 receptor signaling via CREB and AKT and insulin secretory response 199
Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity 199
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 198
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial 195
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 191
Abnormalities of insulin-like growth factor-l Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis 189
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases 189
Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis 189
Wound healing in diabetes: hemorheological and microcirculatory aspects. 186
Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy 180
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy 179
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 173
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 170
PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia 169
GLP-1: a new approach for type 2 diabetes therapy 168
Efficacy and safety of once- weekly dulaglutide versus insulin glargine in patients with type 2 Diabetes on metformin and glimepiride (AWARD-2) 162
Clinical view on the need to develop new anti-diabetic drugs 160
Insulin and Insulin Receptors in Adipose Tissue Development 160
Irisin Increases the Expression of Anorexigenic and Neurotrophic Genes in Mouse Brain 158
Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage? 158
Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis 157
GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells 156
GLP-1 Receptor Agonist Added to Insulin versus Basal-plus or Basal-bolus Insulin Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis 154
Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysin63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy 154
The p66Shc Protein Controls Redox Signaling and Oxidation-Dependent DNA Damage in Human Liver Cells 152
Rare diseases in clinical endocrinology: A taxonomic classification system 152
The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells 150
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes Trials 149
Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment 147
Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway. 147
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan-L trial 147
A master course on "Methodologies for bio-medical research in diabetes". 145
Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome 145
A family history of Type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women 145
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 141
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 140
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 137
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: Clinical consequences and strategies for improvement 136
Adipose Tissue Function and Dysfunction: Organ Cross-Talk and Metabolic Risk 135
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study 134
Interventional therapy in diabetic foot: Risk factors, clinical events and prognosis at one year follow-up (a study of 103 cases) 132
NANOG plays a hierarchical role in the transcription network regulating the pluripotency and plasticity of adipose tissue-derived stem cells 132
Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane 131
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. 131
RAS/BRAF mutational status in familial non‑medullary thyroid carcinomas: A retrospective study 131
Relationship between risk factors and mortality in type 1 diabetic patients in europe: The eurodiab prospective complications study (PCS) 131
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 131
Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial 131
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. 130
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 129
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: A cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 128
The Sentiment Analysis of Tweets as a New Tool to Measure Public Perception of Male Erectile and Ejaculatory Dysfunctions 128
Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism 127
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. 127
Effects of Extra Virgin Olive Oil Polyphenols on Pancreatic Beta-Cell Function and Survival 127
Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway 126
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 126
Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humans. 125
Decreased IRS phosphorylation and altered Erk activation in osteoblasts from osteoporotic subjects. 124
Abnormalities of cardiac insulin signaling in experimental diabetes 124
Biological specificity of visceral adipose tissue and therapeutic intervention 124
Association between physical activity estimated by the International physical activity questionnaire and UKPDS cardiovascular risk in score type 2 diabetes. 123
Ubc9 regulation of glucose transport in 3T3-L1 adipocytes is differentiation-dependent. 122
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. 122
Effect of family history of type 2 diabetes on white blood cell count in adult women 122
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 122
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis 121
IGF-I and IGF-I receptor: implications in the pathophysiology of thyroid cancer 119
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 119
Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia. 119
Adipose tissue precursor cells 118
Correction of Intermittent Hypoxia with CPAP Improves Cardiometabolic Abnormalities, and Systemic and Adipose Tissue Inflammation in Obese Subjects with Obstructive Sleep Apnea. 117
Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome 117
Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index 117
The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion 117
Different gene expression in human heart tissue and progenitor cells from control and diabetic subjects: relevance to the pathogenesis of human diabetic cardiomyopathy 116
TNFα Signals via p66(Shc) to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells 116
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study 115
Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis. 115
Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling 115
Apoptotic and survival signals triggered by high glucose in human mesangial cells. 114
The SUMO-conjugating enzyme Ubc9 is essential for insulin-responsive glucose transport in adipocytes. 114
Associated hormonal declines in aging: DHEAS 114
Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts 114
Gut: A key player in the pathogenesis of type 2 diabetes? 114
Chronic palmitate excess results in reduced exendin-4 action and signalling via CREB and Akt in pancreatic beta cells 114
Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications. 113
Association between differentiated thyroid carcinoma and chronic lymphocytic thyroiditis: a post-hoc evaluation in patients undergoing total thyroidectomy 113
Effects of CPAP on testosterone levels in patients with obstructive sleep apnea: a meta-analysis study 113
CLU TRANSCRIPT VARIANTS AS POTENTIAL BIOMARKERS FOR THE THYROID CANCER 112
Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies 112
Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: A systematic review and meta-analysis 112
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. 111
Atrial natriuretic factor (ANF) in obesity: metabolic clearance rate, platelet clearance receptor number and effectiveness. 111
Role of p66Shc in Cytokine-Mediated Leukocyte Recruitment by Endothelial Cells 111
Efficacy of Vandetanib in treating locally advanced or metastatic medullary thyroid carcinoma according to RECIST Criteria: A systematic review and meta-analysis 111
Irisin Enhances Pancreatic Beta-Cell Survival and Insulin Secretion and Can Mediate the Metabolic Cross Talk between the Skeletal Muscle and Endocrine Pancreas 111
Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects 111
Carriers of the TCF7L2 rs7903146 variant with GMD have an increate risk of developing impaired glucose regulation after pregnancy. 110
Totale 13.812
Categoria #
all - tutte 209.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 209.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.642 0 0 0 0 0 194 561 387 451 558 246 245
2021/20223.384 128 468 31 214 127 179 106 200 252 222 581 876
2022/20235.254 761 491 261 471 651 762 78 575 978 40 101 85
2023/20241.834 158 380 107 128 179 413 39 157 23 50 13 187
2024/20258.840 128 124 710 295 233 907 667 825 445 481 1.334 2.691
2025/20269.802 2.727 841 1.169 2.139 2.105 821 0 0 0 0 0 0
Totale 46.485